ClinicalTrials.gg
Sign In

Adenocarcinoma clinical trials

The registry lists 620 studies for Adenocarcinoma across more than 10 countries. 148 are recruiting or about to start. 167 of them are mainly about Adenocarcinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 37 narrower conditions too, such as Carcinoma, Hepatocellular: 9,054 studies, 2,335 open.

ClinicalTrials.gov finds 13,372 studies for Adenocarcinoma. How that becomes 620 here

This page counts the studies the registry files under Adenocarcinoma, and those it files under no condition that list Adenocarcinomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 13,372Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −7,955Filed under a narrower condition, counted on its own pageCarcinoma, Hepatocellular 3,370 · Carcinoma, Renal Cell 1,811 · Cholangiocarcinoma 640 · Adenocarcinoma of Lung 385 · Adenocarcinoma Of Esophagus 310 · Carcinoma, Intraductal, Noninfiltrating 283 · 28 more
  3. −2,950List Adenocarcinoma as a condition, but the registry did not file them under itMost often written as “Prostate Adenocarcinoma” (249), “Pancreatic Ductal Adenocarcinoma” (238), and “Pancreatic Adenocarcinoma” (232). The registry filed 1,028 of them under no condition at all, and the others under other conditions only, most often Pancreatic Neoplasms (450) and Prostatic Neoplasms (337).
  4. −1,847Match it another way988 name it in the title, 825 in a keyword, and 34 by a synonym or other text the search reads.
  5. 620The count on this page

Get an email when these change. Save the Adenocarcinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
273
Recruiting
111
Terminated
69
Status unknown
58
Active, not recruiting
40
Not yet recruiting
29

Phase

Phase 2
278
Phase 1
152
Phase 3
66
Phase 4
15
Early Phase 1
5

Where

United States
307
France
83
China
77
Germany
57
United Kingdom
53
Spain
53

Who runs them

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (13) · M.D. Anderson Cancer Center (13) · National Cancer Institute (NCI) (13) · Novartis Pharmaceuticals (11) · H. Lee Moffitt Cancer Center and Research Institute (10) · UNICANCER (10) · University Health Network, Toronto (8) · Stanford University (8)

What is being tested here

Drugs under test in Adenocarcinoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Docetaxel5316
Oxaliplatin4217
Gemcitabine3022
Paclitaxel3118
Pembrolizumab3013
Albumin-Bound Paclitaxel3113
Cemiplimab314
Capecitabine2013
Leucovorin2210
Zolbetuximab235

Drug classes tested here Immune checkpoint inhibitors 15 open · Antimetabolites 8 open · Antimitotic agents 8 open · Tyrosine kinase inhibitors (TKIs) 7 open · Antibody-drug conjugates (ADCs) 2 open

Coming up

24phase 3 studies under way
47studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 110 Adenocarcinoma studies recruiting now, 81 (74%) set no upper age limit and 11 (10%) stop at 75 or younger. 7 (6%) take children under 18. 1 (1%) are for women only and 40 (36%) for men only; 4 (4%) take healthy volunteers.

Recruiting studies that take each age, of 110
AgeWomenMen
102 (2%)4 (4%)
1868 (62%)100 (91%)
3070 (64%)103 (94%)
4069 (63%)105 (95%)
5069 (63%)106 (96%)
6569 (63%)108 (98%)
7568 (62%)106 (96%)
8557 (52%)91 (83%)

Across all 620 studies, recruiting or not: 10% stop at 75 or younger and 1% at 65; 5% take children; 4% are for women only and 15% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Adenocarcinoma studies take

Of 93 phase 2 interventional studies under Adenocarcinoma, half reached primary completion within 60 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 144 mo24–64 · 50 studies——
Phase 1/251 mo41–84 · 33 studies——
Phase 260 mo35–82 · 93 studies—64 mo48–94 · 71 studies
Phase 391 mo44–101 · 26 studies——
Interventional, no phase50 mo24–170 · 40 studies——
Observational41 mo30–114 · 44 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting3

Results posted1

Stopped1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 620. Browse all 620 → or search them.